| Literature DB >> 30981862 |
Allison M Cleymaet1, Shannon K Gallagher2, Ryan E Tooker2, Mikhail Y Lipin2, Jordan M Renna3, Puneet Sodhi4, Daniel Berg3, Andrew T E Hartwick4, David M Berson3, Jozsef Vigh5.
Abstract
Intrinsically photosensitive retinal ganglion cells (ipRGCs) encode light intensity and trigger reflexive responses to changes in environmental illumination. In addition to functioning as photoreceptors, ipRGCs are post-synaptic neurons in the inner retina, and there is increasing evidence that their output can be influenced by retinal neuromodulators. Here we show that opioids can modulate light-evoked ipRGC signaling, and we demonstrate that the M1, M2 and M3 types of ipRGCs are immunoreactive for μ-opioid receptors (MORs) in both mouse and rat. In the rat retina, application of the MOR-selective agonist DAMGO attenuated light-evoked firing ipRGCs in a dose-dependent manner (IC50 < 40 nM), and this effect was reversed or prevented by co-application of the MOR-selective antagonists CTOP or CTAP. Recordings from solitary ipRGCs, enzymatically dissociated from retinas obtained from melanopsin-driven fluorescent reporter mice, confirmed that DAMGO exerts its effect directly through MORs expressed by ipRGCs. Reduced ipRGC excitability occurred via modulation of voltage-gated potassium and calcium currents. These findings suggest a potential new role for endogenous opioids in the mammalian retina and identify a novel site of action-MORs on ipRGCs-through which opioids might exert effects on reflexive responses to environmental light.Entities:
Keywords: intrinsically photosensitive ganglion cell; opioids; retina
Mesh:
Substances:
Year: 2019 PMID: 30981862 PMCID: PMC6604633 DOI: 10.1016/j.neuroscience.2019.04.005
Source DB: PubMed Journal: Neuroscience ISSN: 0306-4522 Impact factor: 3.590